Joseph Flores‐Toro

743 total citations
9 papers, 527 citations indexed

About

Joseph Flores‐Toro is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Joseph Flores‐Toro has authored 9 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Joseph Flores‐Toro's work include Autophagy in Disease and Therapy (5 papers), Calpain Protease Function and Regulation (2 papers) and Mitochondrial Function and Pathology (2 papers). Joseph Flores‐Toro is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Calpain Protease Function and Regulation (2 papers) and Mitochondrial Function and Pathology (2 papers). Joseph Flores‐Toro collaborates with scholars based in United States. Joseph Flores‐Toro's co-authors include Jeffrey K. Harrison, Duane A. Mitchell, Rajinder Singh, Thomas J. Schall, Rakesh K. Jain, James J. Campbell, Matthew R. Sarkisian, Defang Luo, Adithya Gopinath and Meenal Datta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cell Death and Differentiation and Pharmacology & Therapeutics.

In The Last Decade

Joseph Flores‐Toro

8 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Flores‐Toro United States 8 252 167 142 122 96 9 527
Lei Gong China 16 165 0.7× 259 1.6× 159 1.1× 79 0.6× 37 0.4× 38 679
Marie‐Camille Rowell Canada 7 129 0.5× 290 1.7× 96 0.7× 45 0.4× 32 0.3× 9 601
Teh‐Wei Wang Japan 7 143 0.6× 134 0.8× 78 0.5× 49 0.4× 21 0.2× 8 407
Emmanuelle Saint‐Germain Canada 8 143 0.6× 396 2.4× 117 0.8× 49 0.4× 33 0.3× 11 735
Thérèse Hervèe Mayi France 7 273 1.1× 184 1.1× 52 0.4× 176 1.4× 10 0.1× 9 519
Shoichi Nagai Japan 15 54 0.2× 228 1.4× 70 0.5× 140 1.1× 180 1.9× 45 642
Ana Fernández Ruiz Canada 5 109 0.4× 194 1.2× 52 0.4× 35 0.3× 25 0.3× 6 471
Sally Yu Shi Canada 13 74 0.3× 235 1.4× 79 0.6× 175 1.4× 26 0.3× 21 536
Muriel G. Blin United States 7 104 0.4× 179 1.1× 38 0.3× 73 0.6× 14 0.1× 10 366

Countries citing papers authored by Joseph Flores‐Toro

Since Specialization
Citations

This map shows the geographic impact of Joseph Flores‐Toro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Flores‐Toro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Flores‐Toro more than expected).

Fields of papers citing papers by Joseph Flores‐Toro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Flores‐Toro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Flores‐Toro. The network helps show where Joseph Flores‐Toro may publish in the future.

Co-authorship network of co-authors of Joseph Flores‐Toro

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Flores‐Toro. A scholar is included among the top collaborators of Joseph Flores‐Toro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Flores‐Toro. Joseph Flores‐Toro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Flores‐Toro, Joseph, Joan Campbell-Tofte, William C. Chapman, et al.. (2021). Critical Roles of Calpastatin in Ischemia/Reperfusion Injury in Aged Livers. Cells. 10(8). 1863–1863. 8 indexed citations
2.
Flores‐Toro, Joseph, et al.. (2020). Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy. Pharmacology & Therapeutics. 222. 107790–107790. 38 indexed citations
3.
Yang, Changlin, Michael Andrews, Aida Karachi, et al.. (2020). TAMI-19. METABOLIC INTERACTIONS BETWEEN TUMOR CELLS AND THE IMMUNE SYSTEM IN GBM: A POTENTIAL ACHILLES HEEL OF GBM FOR NOVEL THERAPEUTICS. Neuro-Oncology. 22(Supplement_2). ii217–ii217.
4.
Rahman, Maryam, W. Gregory Sawyer, Scott Lindhorst, et al.. (2020). Adult immuno-oncology: using past failures to inform the future. Neuro-Oncology. 22(9). 1249–1261. 21 indexed citations
5.
Flores‐Toro, Joseph, Defang Luo, Adithya Gopinath, et al.. (2019). CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proceedings of the National Academy of Sciences. 117(2). 1129–1138. 244 indexed citations
6.
Chun, Sung Kook, Sooyeon Lee, Joseph Flores‐Toro, et al.. (2018). Loss of sirtuin 1 and mitofusin 2 contributes to enhanced ischemia/reperfusion injury in aged livers. Aging Cell. 17(4). e12761–e12761. 59 indexed citations
7.
Flores‐Toro, Joseph, Kristina L. Go, Christiaan Leeuwenburgh, & Kim Js. (2016). Autophagy in the liver: cell’s cannibalism and beyond. Archives of Pharmacal Research. 39(8). 1050–1061. 26 indexed citations
8.
Biel, Thomas, Joseph Flores‐Toro, Joseph Dean, et al.. (2015). Sirtuin 1 suppresses mitochondrial dysfunction of ischemic mouse livers in a mitofusin 2-dependent manner. Cell Death and Differentiation. 23(2). 279–290. 93 indexed citations
9.
Js, Kim, Thomas Biel, Do‐Sung Kim, et al.. (2013). Carbamazepine suppresses calpain-mediated autophagy impairment after ischemia/reperfusion in mouse livers. Toxicology and Applied Pharmacology. 273(3). 600–610. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026